Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 4/2013

Ausgabe 4/2013

Inhaltsverzeichnis ( 15 Artikel )

01.12.2013 | editorial | Ausgabe 4/2013

Antibody–drug conjugates (ADCs)—new targeted therapies

Dr. Georgios Papakonstantinou MD, PhD

01.12.2013 | editorial | Ausgabe 4/2013

Neurooncology: current findings and challenges for the future

Silvia Hofer MD

01.12.2013 | short review | Ausgabe 4/2013

ASCO 2013: news in early-stage and advanced breast cancer

Günther G. Steger, Rupert Bartsch

01.12.2013 | special report | Ausgabe 4/2013

Recent developments in the palliative treatment of breast cancer: ASCO 2013

Univ. Prof. Dr. Edgar Petru MD, Univ. Ass. Dr. Tina Idris, Univ. Ass. Dr. Vassilliki Kolovetsiou, Univ. Ass. Dr. Eva Schest

01.12.2013 | short review | Ausgabe 4/2013

ASCO 2013: new developments in lung cancer

Andreas Pircher MD, Assoc. Prof. Michael Fiegl MD, Florian Kocher MD, Assoc. Prof. Wolfgang Hilbe MD

01.12.2013 | short review | Ausgabe 4/2013

ASCO annual meeting 2013: head and neck cancer

Dr. Georg Pall

01.12.2013 | short review | Ausgabe 4/2013

ASCO 2013—treatment of metastatic melanoma: is it still a story of success?

ao. Univ.-Prof. Dr. Georg Weinlich MD

01.12.2013 | short review | Ausgabe 4/2013

Update on neurooncology Annual meeting of the American Society of Clinical Oncology (ASCO) 2013

Silvia Hofer MD, Christine Marosi

01.12.2013 | comment | Ausgabe 4/2013

ASCO 2013—new concepts and the path to individualized therapy

Univ. Prof. Dr. Heinz Zwierzina

01.12.2013 | short review | Ausgabe 4/2013

Transfusion-associated graft-versus-host disease: an update

Christian Dal-Pont MD, Assoc. Prof. Dr. Harald Schennach MD

01.12.2013 | short review | Ausgabe 4/2013

The contribution of antibodies to targeted cancer therapy

Panagiotis Apostolou, Dr. Ioannis Papasotiriou

01.12.2013 | short review | Ausgabe 4/2013

Targeted delivery of anticancer agents using antibodies as vectors

Maria Toloudi MD, Ioannis Papasotiriou MD, PhD

01.12.2013 | review | Ausgabe 4/2013

T-DM1 in breast cancer therapeutics: the first drug of its generation

Michalis V Karamouzis MD, PhD

01.12.2013 | short review | Ausgabe 4/2013

Targeting AML with anti-CD33 antibodies: historical walkthrough, clinical impact, future directions

Spyridon Dimitrios Chondropoulos MD, Annaliza Delastic MD, Alexandros Spyridonidis MD

01.12.2013 | short review | Ausgabe 4/2013

Brentuximab vedotin, a highly active ADC as a new therapeutic option for CD30+ lymphomas

Sofia Stamatopoulou MD

Aktuelle Ausgaben